欧洲疾控中心-2024_25年欧盟_欧洲经济区国家季节性流感疫苗接种建议和覆盖率调查报告

ECDCSURVEILLANCE & MONITORING Survey report on national seasonalinfluenza vaccination recommendations This report of the European Centre for Disease Prevention and Control (ECDC) was coordinated and written by BahaaAldin Alhaffar, with contributions from Sabrina Bacci, Nathalie Nicolay. The following experts reported data on influenza vaccination coverage and contributed to the interpretation of thelevel and trend in vaccination coverage observed in their countries: Austria: Jiale Lin;Belgium:Laura Cornelissen, Cato Dambre, Laurane De Mot;Bulgaria:Nadezhda Vladimirova;Croatia:Bernard Kaić, Vesna Višekruna Vučina;Cyprus: Anna Papandreou Kazamia;Czechia: Jan Kyncl;Denmark:Ida Rask Moustsen-Helms;Estonia:Irina Filippova, Keiti Aren;France:Rémi Hanguehard, LaureFonteneau;Finland:Ulrike Baum, Camilla Jordman, Hanna Nohynek,;Germany: Johanna Schlaberg, ThorstenRieck, Cornelius Rau;Greece: Stella Vorre, Theano Georgakopoulou, Theodora Stavrou;Hungary: ZsuzsannaMolnár; Katalin Kaszás;Iceland: Kamilla Sigríður Jósefsdóttir ;Ireland:Jolita Mereckiene, Eimear Keane,PiarasO'Lorcain, Lois O’Connor;Italy:Antonino Bella, Anna Caraglia, Cristian Ferrao;Latvia:Karīna Venediktova, LindaKrauze;Liechtenstein: Esther Walser-Domjan, Carla Visscher;Lithuania:GretaGargasienė;Luxembourg: JoëlMossong, Silvana Masi;Malta: Justine Farrugia Preca, Tanya Melillo;theNetherlands:Imke Schreuder, AnneTeirlinck;Norway:Hilde Bakke;Poland:Katarzyna Łuniewska,Katarzyna Kondratiuk,Karol Szymański,IwonaParadowska-Stankiewicz;Portugal: Bruno Alves, Natália Pereira, Susana Cardoso;Romania:Rodica Popescu;Slovakia: Helena Hudecova;Slovenia:Irena Kavšek, Luka Kosec,Veronika Učakar, Marta Grgič Vitek;Spain: Suggested citation: European Centre for Disease Prevention and Control. Survey report on national seasonalinfluenza vaccination recommendations and coverage rates in EU/EEA countries, 2024/25. Stockholm: ECDC; 2025. Stockholm, November 2025 ISBN 978-92-9498-840-9doi: 10.2900/4170165Catalogue number TQ-01-25-070-EN-N Contents Abbreviations......................................................................................................................................................... iiExecutive summary ................................................................................................................................................1Highlights on policies, recommendations and vaccination cover rates in key target groups.......................................1Introduction ..........................................................................................................................................................2Purpose and audience .......................................................................................................................................2Background ......................................................................................................................................................2Survey objectives..............................................................................................................................................2Methods ................................................................................................................................................................3Study design ....................................................................................................................................................3Data collection..................................................................................................................................................3Data analysis ....................................................................................................................................................3Data validation .................................................................................................................................................3Results..................................................................................................................................................................4Response rate ..................................................................................................................................................4Seasonal influenza vaccine recommendations ......................................................................................................4Age-based recommendations for children and adolescents................................................................................4Age-based recommendations for adults ..........................................................................................................4Recommendations for individuals with chronic medical conditions .....................................................................4Recommendations for pregnant women ..........................................................................................................5Recommendations